WAPNICK PAMELA (Chief Financial Officer) sold 2.5% of their position (1.56K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/6/2024ACC: 0000950170-24-134124
Officer· Chief Financial Officer
Since Mar 2026
-1.56K
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.56K
Price / share
$1.86
Trade value
$2.90K
% of position
2.5%
12/5/2024
63.05K→61.49K
Total
Net shares
−1.56K
Net value
-$2.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2024 | S · Sale | −1.56K | $1.86 | $2.90K | 2.5% | 63.05K | 61.49K |
| Total | −1.56K | -$2.90K | ||||||
Derivative Transactions0
No derivative transactions reported